Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

NGNENGNE
Showing 8 of 11 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in NEUROGENE INC

BAKER BROS. ADVISORS LP holds 991,691 shares of NGNE (NEUROGENE INC), worth $31.2M as of 2026-Q2. NGNE represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$31.2M

Current Shares

991,691

Total Value Change

+$12.1M

Total Shares Change

+535,676

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
991,691
0.0%
$31.2M0.2%$31.45
0
2026-Q1
Unchanged
991,691
0.0%
$20M0.1%$21.99
0
2025-Q4
Unchanged
991,691
0.0%
$20.4M0.1%$22.11
0
2025-Q3
Unchanged
991,691
0.0%
$17.2M0.1%$17.71
0
2025-Q2
Decreased
991,691
-33.3%
$14.8M0.1%$16.16
0
2025-Q1
Increased
1.5M
+120.4%
$17.4M0.2%$14.52
55
2024-Q4
Increased
674,450
+47.9%
$15.4M0.2%$22.28
46
2024-Q3
Unchanged
456,015
0.0%
$19.1M0.2%$40.33
0

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used